Epigenomics AG is a molecular diagnostics company developing and manufacturing a pipeline of products for the diagnosis of cancer.
Epigenomics AG has raised €9.8M across 2 funding rounds, most recently a round in Oct 2014. Based in Berlin, Germany; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2014-10-01 | Other | €4.8M | — | View deal → |
| 2013-08-01 | Other | €5.0M | — | View deal → |
